The latest funding round will fuel Weimai’s efforts to expand its full-cycle healthcare solutions, leveraging AI and digital tools to provide comprehensive care across the country. China
HANGZHOU, China, January 7, 2025 /PRNewswire/ — Weimai, a leading provider of one-stop digital healthcare solutions in Chinahas finalized a Series D financing round, raising 200 million yuan ($27.3 million).
The funds will support the expansion of its comprehensive health services aimed at meeting the growing demand for long-term comprehensive medical care.
The latest round of financing attracted new investors, including CNCB INVESTMENT, CHOICE CAPITAL, Yuhang Transformation Industry Investment, Deqing Industry Development Investment and Nanhu Investment.
Existing shareholders Source Code Capital, Cenova Ventures and Vision+ Capital also participated in this round. Proceeds will be used to accelerate Weimai’s development of disease management solutions and AI-related research.
Founded in 2015, Weimai has become China the largest online full-cycle healthcare management platform, addressing the need for seamless healthcare services through its proprietary “Managed Care Organization” (MCO) business model.
Qiu Jialin, founder and CEO of Weimai, commented: “MCO is a new concept in China. Over the past nine years, we have systematically integrated MCO into management practices. China healthcare reforms, pioneering a uniquely Chinese approach to managed care: C-MCO. »
“Through technological empowerment, we have improved healthcare services to provide full-cycle management and closed-loop services in pre-hospital, intra-hospital and post-hospital scenarios,” Qiu added.
Under this model, Weimai focuses on meeting the needs of extensive and diversified services in post-diagnosis, post-test, post-surgery, post-hospitalization medication, follow-up consultation, diet nutrition, exercise and rehabilitation.
Centered around patient needs, Weimai provides integrated healthcare management services that combine online and offline, in-hospital and out-of-hospital care, covering the full range of pre-hospital scenarios , intra-hospital and post-hospital.
This service model significantly improves the efficiency and quality of healthcare services while improving patients’ medical experience and recovery outcomes.
Fang Sheng, Head of Financing Division of CNCB INVESTMENT, noted: “The continuously expanding business landscape and improving financial performance over the past three years reflect the mature management capabilities of the Weimai team. difficult path. »
Chen Duinvestment manager at Yuhang Transformation Industry Investment, said: “Amidst the wave of digital healthcare, Weimai’s business model stands out. It precisely targets its development direction, deeply integrates digital technology with medical services, and significantly stimulates the improvement of healthcare consumption. I firmly believe that Weimai will continue to lead the transformation of the industry and usher in a broader future for public health. »
Of the December 31, 2024Weimai has connected with more than 2,500 public healthcare institutions and 200,000 licensed doctors nationwide, serving a cumulative 1 billion patients.
At the heart of Weimai’s offerings is its pre-trained AI model, CareAI, which automates health assessments and self-screenings, improving triage and referral processes. Launched in 2023, CareAI also enables efficient data retrieval for doctors and integrates with platforms such as hospital apps and WeChat, providing multi-format health management guidance throughout the care process.
With increasing per capita disposable income, aging population and growing health awareness, the demand for quality healthcare services continues to grow. China.
In this context, expanding the supply of health services and extending the reach of health services have become essential for the development of China health system.
As a pioneer of this trend, Weimai integrates ecosystem resources and integrates commercial insurance into its management services, creating a “healthcare-pharmaceutical insurance” closed-loop service model.
This approach strengthens proactive disease management and improves the patient service experience, enabling residents in lower-tier regions to access comprehensive health management services covering prevention, diagnosis, treatment and rehabilitation .
With the vision of creating “smart hospitals without walls”, Weimai is dedicated to providing comprehensive, personalized and long-term healthcare services to meet the changing needs of the public and align with China national health strategy.
About Weimai
A pioneer in digital management of the complete healthcare cycle, Weimai has become China largest platform in this sector. Leveraging its proprietary CareAI technology, Weimai has been driving the widespread adoption of comprehensive care management solutions since 2015.
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/weimai-bags-rmb200m-in-series-d-funding-to-enhance-tech-enabled-continuous-healthcare-services-302344084.html
SOURCE Weimai
